Longeveron Inc. (LGVN)
NASDAQ·Healthcare·Biotechnology
$1.84
+1.66%
Mkt Cap $20.02M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+443.5%
Consensus $10.00 vs current $1.84
NASDAQ·Healthcare·Biotechnology
$1.84
+1.66%
Mkt Cap $20.02M
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
+443.5%
Consensus $10.00 vs current $1.84